Kevin J. Yeaman Sells 25,000 Shares of Dolby Laboratories (NYSE:DLB) Stock

Key Points

• CEO Kevin J. Yeaman sold 25,000 shares of Dolby Laboratories stock at an average price of $72.31, totaling approximately $1.8 million, resulting in a 17.89% decrease in his ownership.
• Dolby Laboratories recently reported a quarterly earnings per share of $0.78, exceeding expectations, with a revenue of $315.55 million, reflecting a 9.2% year-over-year growth.
• The company announced a quarterly dividend of $0.33 per share, with a payout ratio of 48.35%, and a dividend yield of 1.8%.

Dolby Laboratories (NYSE:DLB - Get Free Report) CEO Kevin J. Yeaman sold 25,000 shares of the firm's stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $72.31, for a total transaction of $1,807,750.00. Following the transaction, the chief executive officer directly owned 114,725 shares of the company's stock, valued at $8,295,764.75. This represents a 17.89% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Dolby Laboratories Stock Performance

Shares of DLB traded down $0.0190 during mid-day trading on Tuesday, reaching $73.7810. The company had a trading volume of 355,596 shares, compared to its average volume of 387,873. The company has a market capitalization of $7.07 billion, a price-to-earnings ratio of 27.03 and a beta of 0.91. The firm has a 50-day moving average price of $74.37 and a 200 day moving average price of $76.83. Dolby Laboratories has a 52 week low of $68.24 and a 52 week high of $89.66.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The business had revenue of $315.55 million during the quarter, compared to analysts' expectations of $305.23 million. During the same quarter in the previous year, the business earned $0.71 earnings per share. The firm's quarterly revenue was up 9.2% compared to the same quarter last year. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, research analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Tuesday, August 12th. Dolby Laboratories's dividend payout ratio (DPR) is currently 48.35%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of DLB. Palogic Value Management L.P. grew its position in Dolby Laboratories by 6.4% in the fourth quarter. Palogic Value Management L.P. now owns 3,888 shares of the electronics maker's stock worth $304,000 after acquiring an additional 235 shares in the last quarter. Russell Investments Group Ltd. increased its stake in Dolby Laboratories by 5.5% in the fourth quarter. Russell Investments Group Ltd. now owns 40,924 shares of the electronics maker's stock worth $3,196,000 after purchasing an additional 2,117 shares during the period. Cerity Partners LLC lifted its holdings in Dolby Laboratories by 33.9% during the 4th quarter. Cerity Partners LLC now owns 14,643 shares of the electronics maker's stock valued at $1,135,000 after buying an additional 3,706 shares in the last quarter. Invesco Ltd. raised its stake in shares of Dolby Laboratories by 8.3% during the fourth quarter. Invesco Ltd. now owns 266,269 shares of the electronics maker's stock valued at $20,796,000 after acquiring an additional 20,431 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in shares of Dolby Laboratories in the 4th quarter worth $1,872,000. 58.56% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

DLB has been the topic of several analyst reports. Barrington Research reiterated an "outperform" rating and issued a $100.00 target price on shares of Dolby Laboratories in a research note on Friday, May 2nd. Wall Street Zen lowered shares of Dolby Laboratories from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Tigress Financial boosted their price target on Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a research note on Friday. Finally, Rosenblatt Securities reiterated a "buy" rating and issued a $95.00 price target on shares of Dolby Laboratories in a research note on Friday, August 1st. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $103.00.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.